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Abstract
Background: Chitosan and its derivates are widely used for biomedical application due to antioxidative,
anti-inflammatory, antimicrobial and tissue repair induced properties. Chitosan-based materials also used as
a haemostatic agent but influence of different molecular weight and concentration of chitosan on biological
response of blood cells is still not clear.
The aim of this research was to evaluate interaction between human blood cells and various forms of chitosan-based
materials with different molecular weight and chitosan concentration and prove their effectiveness on in-vivo model.
Methods: We used chitosan with molecular weight 200, 500 and 700 kDa and deacetylation rate 80-82 %. For
chitosan impregnation of gauze chitosan solutions in 1 % acetic acid with different concentrations (1, 2, 3, 5 %)
were used. We used scanning electron microscopy to obtain information about chitosan distribution on cotton
surface; Erythrocyte agglutination test and Complete blood count test – for evaluation of interaction between
blood cells and chitosan-based materials with different compound. In-vivo studies was performed in 20 Wistar
rats to evaluate effectiveness of new dressing.
Results: Our data shown that chitosan can bind erythrocytes in concentration-depend manner that does not depend
on its molecular weight. In addition, chitosan-based materials affect selectively human blood cells. Composition of
chitosan with cotton materials does not change erythrocyte shape and does not cause agglutination.
Conclusions: Сotton-chitosan materials have higher adhesive properties to platelets that depend on molecular
weight and concentration of chitosan. These materials also change platelets’ shape that probable is one of
the most important mechanisms of haemostatic effect. In-vivo studies have shown high effectiveness of 2 % 200 kDa
chitosan for stop bleeding from arteries of large diameter.
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Background
Adequate haemostasis after trauma and during surgical
operation is a big challenge in modern medicine. About
40 % traumatic and more than 90 % of combat deaths
took place in pre-hospital settings. And about 50 % from
these deaths have been reported due to massive blood
loss [1]. Sauaia A. reported 80 % of civilian trauma fatal-
ities within the United States caused by uncontrollable
haemorrhage [27]. Also, haemorrhage in trauma patients
is the leading cause of reoperation [8].
Topical haemostatic treatment was applied since an-
cient time. They used herbs, mixture of wax, grease and
barley and also animal hides mixed with hot sand to stop
bleeding [7]. Advances in biotechnology have resulted in
explosive growth of topical haemostatic agents in the
last two decades [18, 21, 22]. At present, the scientific
community is actively searching for materials which
effectively stop the bleeding, but without side effects.
Particular attention is paid to the materials based on
natural polymers (collagen, chitosan and others) [14, 23].
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Chitin and chitosan haemostatic dressing are most
promising due to effective blood stop and possible
additional properties like antibacterial and stimulatory
to regeneration. Chitosan is a linear, semi-crystalline
polysaccharide composed of (1–4)-2-acetamido-2-de-
oxy-b-D-glucan (N-acetyl D-glucosamine) and (1–4)-
2-amino-2-deoxyb-D-glucan (D-glucosamine) units
[26]. It is not extensively present in the environment –
however, it can be easily derived by the partial deacetyla-
tion of a natural polymer chitin (Fig. 1). To be named
“chitosan”, the deacetylated chitin should contain at least
60 % of D-glucosamine residues [4]. Molecular weight of
chitosan typically ranges from 300 to 1000 kDA, depend-
ing on the source and preparation [15].
Chitin and chitosan are biocompatible polymers but
there are some evidences that chitosan is more cytocom-
patible in vitro than chitin [25]. While the number of
positive charges increases, the interaction between cells
and chitosan increases as well, which tends to improve
biocompatibility [5]. Materials, based on chitosan have
no allergic effect in living body and not toxic [20].
The most studied chitosan-based hemostatic dress-
ings for today are Celox and HemCon. Both dressing
were evaluated experimentally and show high effect-
iveness [3, 3, 13, 16].
Various forms of chitosan-based haemostatic mate-
rials (foams, sponges, films, etc.) are developed, the
production of which is expensive. One of the easiest
ways to get haemostatic materials is steeping of an
existing cotton (or other) gauze or bandage in chito-
san to improve its haemostatic properties.
Both clinical and experimental evaluations of chitosan-
based hemostatic dressing suggest their high effectiveness
and safety in civil and battlefield application [10, 15, 23].
But still there is no understanding how does molecular
weight of chitosan influence haemostatic activity of
chitosan-based materials. Also chitosan may be present in
different concentration that can change effectiveness and
time that need to stop bleeding.
The chitosan could have different molecular weight,
deacetylation rate, and could be chemically modified.
Also it is possible to prepare different physical forms:
gels, foams, films, sponges, etc., that increase the num-
ber of potential chitosan-based materials with different
physical, chemical and biological properties [9]. Chitosan
and its derivates are widely used for biomedical applica-
tion due to antioxidative, anti-inflammatory, antimicro-
bial and tissue repair induced properties [29]. Chitosan
derivates are used as haemostatic agents [10, 24]. A lot
of commercial materials are used with this purpose, such
as HemCon, Chitoseal, Celox, Tegasorb, and QuikClot.
They proved high effectiveness in experimental model
as well as in civil and combat trauma. But the influ-
ence of different molecular weight and concentration
of chitosan on biological response of blood cells is
still not clear [2, 19].
The aim of this research was to evaluate interaction
between human blood cells and various forms of
Fig. 1 Chitin and chitosan
Pogorielov et al. Biomaterials Research  (2015) 19:22 Page 2 of 10
chitosan-based materials and prove their effectiveness
on in-vivo model
Methods
Preparation of haemostatic dressings with chitosan
We used chitosan with molecular weight (MW) 200, 500
and 700 kDa and deacetylation rate 80-82 % (Biopro-
gress, Moscow) in our research For impregnation of
gauze chitosan solutions in 1 % acetic acid with different
concentrations (1, 2, 3, 5 % w/w) were used. Using these
solutions we made following materials with potentials
haemostatic activities:
Gauze-chitosan dressing (G-Ch)
Ten layers of gauze were soaked by chitosan solution in
a ratio 1 to 5. Gauze was dried in thermostat during
24 h at temperature 36 °C.
Finally we obtained 3 different groups of samples:
a. G-Ch dressing with chitosan MW 200 kDa and
chitosan concentration 2 %, 3 % and 5 %;
b. G-Ch dressing with chitosan MW 500 kDa and
chitosan concentration 2 %, 3 % and 5 %;
c. G-Ch dressing with chitosan MW700 kDa
and chitosan concentration 1 % and 2 %.
(1 % solutions of chitosans with MW 200
and 500 kDa are not enough viscous to made
dressings, while 3 % and 5 % solutions of
700 kDa chitosan are too viscous.)
Standard gauze dressing (SGD)
Ten layers of standard cotton gauze were used as a control.
All samples were cut to make thin strip with average
weight 100 mg. Before experiment all materials were
stored in fridge with temperature 4 °C.
Scanning electron microscope
Scanning electron microscopy was performed using the
electron microscope REMMA102 (SELMI, Ukraine) to
obtain information about chitosan distribution on cot-
ton surface. To avoid surface charge accumulation in
the electron-probe experiment standard cotton dressing
and gauze-chitosan dressing were covered with the thin
(30–50 nm) layer of silver in the vacuum set-up VUP-
5 M (SELMI, Ukraine).
To obtain information about the interaction between
blood cells and materials that we used in experiment, after
the haemostasis occure we put SCG and G-Ch to 5 % for-
maldehyde for 1 h, dehydrated samples in ethanol and dried.
Blood
Three human subjects volunteered to have 80 mL of
blood drawn by a registered nurse at the Medical In-
stitute of Sumy State University. The study had been
previously approved by the Ethic Committee on Med-
ical Research of Medical Institute of Sumy State Uni-
versity. An appropriate informed consent was
obtained from all patients. Subjects were healthy
adults in age 20, 22, and 24. 2.5 ml of blood was im-
mediately placed to Becton Dickinson Vacutainers®
with 3.6 mg EDTA for complete blood count (CBC)
test and with 0.109 М sodium citrate – for coagulo-
gram test. 20 ml of blood was centrifuged to made
erythrocyte mass for agglutination test.
Erythrocyte agglutination test
5 ml of erythrocytes were diluted in 95 ml of saline solu-
tion. 0.5 ml of chitosan solution was transferred to “U”
bottom 96-well microplate and 0.1 ml of 5 % erythrocyte
mass was added. The incubation was made in thermo-
stat at 37 °C during 40 min. Hemagglutination was de-
scribed using a scale purposed by Stavitsky:
++++ compact granular agglutinate;
+++ smooth mat on bottom of well with folded edges;
++ smooth mat on bottom of well. Edges somewhat
ragged;
+ narrow ring of red around edge of smooth mat;
– discrete red button in centre of bottom well.
Other presentations were interpreted as undetermined
events.
Blood interaction test
The strips of chitosan-based materials and standard cot-
ton gauze with weight 100 mg was placed to Becton
Dickinson Vacutainers® and incubated in thermostat in
temperature 36 °C during 10 min. All samples were re-
moved and blood transported to the hematology tests.
Untreated blood was used as a control.
Sorption of blood
All samples removed from Becton Dickinson Vacutainers®
with human blood were weighed to evaluate sorption of
blood. It was determined using following formula (1):
S ¼ W1‐W2 ð1Þ
where S – sorption of blood (mg); W1 – sample weight
after experiment (mg); W2 – sample weight before ex-
periment (mg).
Complete blood count test
CBC-test and coagulogram test was performed in
Medical Centre “Floris”. CBC was carried out on the
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haematology analyzer CELL-DYN 3700 (ABBOTT,
USA) using reagents DIAGON (Hungary). We deter-
mined haemoglobin level (HGB, g/L), Red Blood Cells
(RBC, T/L), Mean Corpuscular Volume (MCV, fL),
RBC Distribution Width (RDW, %), Platelets (PTL,
G/L), Mean Platelet Volume (MPV, fL), and Platelet
Distribution Width (PDW, %).
Study of blood coagulation was performed on an auto-
mated analyzer system ACL 7000 (Instrumentation
Laboratory, USA) using reagents RecombiPlasTin 2G
and SynthASil (HemosIL, USA). We determined pro-
thrombin time (PT, sec), prothrombin index (PI, %),
international normalized ratio (INR, EU), fibrinogen (Fg,
gram perliter), and activated partial thromboplastin time
(APTT, sec).
Animals and experiment design
Twenty white laboratory rats (Wistar line) weighing
180–200 g, obtained from Vivarium of Medical Institute
of Sumy State University, were used in the study. Experi-
ment design was approved by Ethical Committee of
Sumy State University.
The rats were divided into two groups of 10 animals
in each to evaluate haemostatic effect of chitosan
dressing.
All animals were anesthetized with ketamine (10 mg
per 1 kg weigh). Medial surface of the tight were
shaved. The access sites in each animal were the
superficial femoral artery (SFA). We cut the medial
surface of SFA of half from its diameter using the
surgical scissors. In first group of animals we apply
SGD with standard manual compression (SMC) for
control bleeding. Second groups received treatment
with G-Ch dressing applied with SMC.
In both groups SMC was provided for 60 s, if the
bleeding continued, SMC was applied for an additional
60 s. If haemostasis was not achieved after 10 min of
treatment uncontrolled haemorrhage was concluded.
After the haemostasis occurred we weighed the SGD
and G-Ch to obtain information about the amount of
blood loss that was determined using following for-
mula (2):
S ¼ W1‐W2 ð2Þ
where S – blood loss (mg); W1 – sample weight after
experiment (mg); W2 – sample weight before experi-
ment (mg).
Statistic methods
Data were expressed as means ± standard deviation.
Student’s t-test on unpaired data was used to assess
the statistical significance of the difference between
the results obtained from the tested specimens. Statis-
tical significance was assumed at a confidence level of
95 % (p < 0.05).
Results
Scanning electron microscopy
Ten layers of SGD made dense network of fibres with
pores from 0.1 to 1.0 mm that allow to absorbed blood
plasma as well as cells. After soaking of cotton with chi-
tosan solution and drying we can see that cotton fibers
are covered with thin layer of chitosan and pores did not
close (Fig. 2). It allows blood to contact with chitosan
and to be absorbed inside the material.
Erythrocyte agglutination test
Complete hemagglutination index (++++) was present in
solution of 3 % and 5 % 500 kDa and 5 % 200 kDa chito-
san (Fig. 3). Weak hemagglutination index (++) is in 3 %
200 kDa chitosan solution. Low percentage chitosan so-
lution (1 % and 2 % of all MW) did not cause
Fig. 2 Microstructure of standard cotton dressing (a) and Gauze-chitosan dressing (b)
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agglutination. In 2 % 700 kDa chitosan solution we
observed undetermined results due to high solution
viscosity.
Sorption of blood
SGD, 2 % G-Ch with MW 200 kDa, 500 kDa and
1 % G-Ch with MW 700 kDa absorbed the same
amount of blood: from 735 to 913.3 g (Fig. 4). 3 %
and 5 % G-Ch with MW500 kDa absorbed significant
less blood compared with the SGD and 2 %
500 kDa G-Ch dressing. Also 3 % G-Ch with MW
500 kDa absorbed significant more blood compared
to the 5 % ones. Blood sorption by 3 % and 5 % G-
Ch with MW 200 kDa is significantly less compared
to the SGD and 2 % 200 kDa G-Ch dressing. But
there is no significant difference between 3 % and
5 % 200 kDa G-Ch materials. Also we did not see
difference between dressing with the same percentage
of chitosan but different MW.
CBC-test
Blood coagulation test did not show any changes of coa-
gulogramm and difference between SGD and chitosan-
based materials.
During the CBC-test we focused on Red Blood Cells
and Platelets parameters. Current experiment did not
show any significant differences between control (un-
treated blood) and blood that interacted with chitosan-
based materials in RBC concentration, haemoglobin
level, RBC Distribution Width, and Mean Corpuscular
Volume (Fig. 5).
Compared with the RBC, amount of platelets and its
parameters significantly changed depending on MW,
percentage of chitosan in solution and type of material
(Fig. 6). All types of G-Ch dressings made from
200 kDa MW chitosan significantly decreased platelets
amount in blood in 10 min after incubation. Materials
made from 2 % chitosan solution have the strongest ef-
fect: platelets level decreased compared with the control
group by 23.03 % (p ≤ 0.001). Samples of chitosan MW
Fig. 3 Results of hemagglutination of human erythrocyte in chitosan solutions
Fig. 4 Blood sorption by the SGD and chitosan-based materials in 10 min after blood incubation
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700 kDa significantly decreased platelets level, but the
difference was not more than 8.33 % (p = 0.023). Mate-
rials made from 500 kDa chitosan did not change plate-
lets level except the samples of 3 % solution that caused
significant depression of cell concentration in blood.
Our data show that all types of G-Ch dressing af-
fected Mean Platelet Volume. Materials made from
chitosan with MW 500 kDA caused more significant
augmentation of platelets volume compared to 200
and 700 kDa samples. Most prominent difference we
can see for materials made from 2 % solution of
500 kDa MW chitosan: it is equal to 21.63 % (p ≤ 0.001).
Platelet Distribution Width changed only in blood
samples that interacted with 2 % chitosan with MW
200 and 700 kDa. All other samples did not affect
this parameter.
Fig. 5 Difference (in %) of HGB, RBC, RDW, and MCP between the control untreated blood (zero line) and blood that interacted with
chitosan-based materials
Fig. 6 Difference (in %) of platelets, MPV, and PDW between the control untreated blood (zero line) and blood that interacted with
chitosan-based materials
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In-vivo experiment
For in-vivo experiment we have used G-Ch with MW
200 kDa and concentration of 2 % due to its in-vitro
effectiveness. We see the effectiveness of G-Ch dressing
in 9 form 10 animals compare the SGD that stop bleed-
ing in 20 % from all cases (Table 1).
Time of haemostasis and amount of blood loss were
determined in survived animals only (Fig. 7). Time of
haemostatis after application of G-Ch (256 ± 24.71 s)
was in two times less compare the SGD (510 ± 11.34)
seconds. Animals that were treat using G-Ch loss 105 ±
17.32 mg of blood, but application of SGD lead massive
blood loss - 1046 ± 164.43 mg during the haemostatic
procedure.
Scanning electron microscopy show that blood cells
pure adhere to SGD. We can see (Fig. 8) that erythro-
cytes slightly spread on dressing surface, have usual
shape and do not aggregate.
Compare to this results, G-Ch dressing adhere a lot of
red blood cells. Erythrocytes imbed to the loose sub-
stance, that is probably chitosan on gauze surface. We
can see that almost all cells change their shape and looks
like spherocyte.
Discussion
The chitosan could have different molecular weight,
deacetylation rate, and could be chemically modified.
It is a cationic polymer and can bind red blood cells
due to their anionic nature [17]. Hemagglutination
assay in current experiments shows that erythrocyte
agglutination strongly depends on chitosan concentra-
tion in solution and doesn’t significantly depend on
its molecular weight. All samples with chitosan con-
centration from 3 % to 5 % show agglutination, while
1 % and 2 % do not. Erythrocyte aggregation in
chitosan solution as well as films and chitosan nano-
particles is presented in some research but they did
not show relations between chitosan concentration
and agglutination effect. Moreover, S.B. Rao has
shown that 2 % of chitosan nanoparticle-based film
causes hemagglutination [24]. In our research we ob-
served weak agglutination only in 2 % solution of
200 kDa chitosan, other molecular weight chitosans
with same concentration did not cause erythrocyte
aggregation. Probably, high concentration chitosan so-
lutions have more protonated groups and thus more
chances to bind with erythrocyte wall. But extremely
high concentration increases the viscosity of chitosan
solution and decreases agglutination effect. Our ex-
periments show that high molecular weight increases
viscosity and it is simpler to made high concentration
solution from low molecular weight chitosan with
same agglutination effect.
Sorption properties are important for a haemo-
static agent due to possibility of fast plasma sorption
and increasing concentration of blood cells, espe-
cially RBC and platelets, near injured vessel. Our
data proved that materials made from cotton and
middle and high MW chitosan absorbed the same
amount of blood as a standard cotton dressing. Low
MW chitosan significantly decrease sorption proper-
ties of cotton dressing.
CBC test did not show difference in RBC number as
well as their volume and width. Some researchers
showed that chitosan-based materials can change
erythrocyte shape but they did not prove RBC adhe-
sion on chitosan. Klokkevold et al. revealed that eryth-
rocytes from anesthetized rabbits lost their typical
biconcave morphology and appeared to have an un-
usual affinity towards one another [11]. Kind et al. did
not see any RBC change after the contact with chito-
san material [10]. Current experiments shown that
influence on RBC depends on form of chitosan: solu-
tion with high concentration caused erythrocyte co-
agulation but chitosan-based dressing did not affect
normal human RBC.
Platelets are the essential mediators that trigger
the mechanical pathway of the coagulation cascade.
Table 1 Effectiveness of haemostasis during the in-vivo
experiment
Group N Complete haemostasis
up to 10 min
% of effectiveness
SCG 10 2 20
G-Ch 10 9 90
Fig. 7 Time of complete haemostasis (a) and blood loss (b) after application of SGD and G-Ch dressings
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Previous researches have shown that platelets adhered to
chitosan-based materials in time and concentration-
dependent manner [6]. Shen et al. discovered that
chitosan induced platelet adhesion and aggregation by
noting that the level of aggregation was related to the
concentration of the platelets in the plasma [28]. Our
data shown that level of platelets significantly de-
crease in blood in 10 min of chitosan interaction that
proved their adhesion to chitosan-based material. The
adhesion depends on molecular weight and concen-
tration. Low and high MW chitosan-cotton dressing
significantly decrease platelets level while middle MW
have no same affect. High concentration of chitosan
(3 % and 5 %) decrease platelets adhesion. Platelets
shape (volume and width) changed in all chitosan-
cotton groups but the most significant changes were
observed for 500 kDa chitosan samples. Probably,
Low and High molecular weight chitosan adsorbed
more platelets and possibly changed their shape, and
we did not see it in the remnant of blood. Middle
molecular weight chitosan did not adsorb a lot of
cells but significantly changed their shape. The same
morphological parameters of platelets were observed
during the clot formation that proved haemostatic po-
tential of chitosan-based materials. The mechanisms
that induce platelets adhesion and activation by chito-
san are still not understood completely. There are
some evidences that chitosan can activate Glycopro-
tein IIb/IIIa and discharge thromboxane A2/ADP and
these signals elevate platelet spreading and strengthen
the stability of adhesion [28].
In-vivo results shown 90 % effectiveness of chitosan-
based dressing compare the 20 % in control group with
SGD. In several studies, chitosan based materials pro-
vides up to 100 % effectiveness during different injury
models [12, 21]. It is very important the time of
haemostasis and amount of blood loss during treat-
ment. Our data shown that application of gauze-
chitosan dressing decrease these parameters in 2 and
10 times compare the SGD. Koksal O. and coauthors
shown that Celox stop bleeding in rats that used anti-
coagulants after 90 s compare the standard manual
compression that was ineffective [11]. Other chitosan-
based dressing – HemCon, stop bleeding after 6.94 ±
3.9 min in SFA trauma in ship model.
To summarize our results and literature data about
chitosan action on blood coagulation and haemostasis
we propose mechanism of action of our dressing
made by the impregantion of cotton gauze with chito-
san solution.
Standard cotton gauze after application sorbed plasma
and blood cells but the last one did not adhere to dress-
ing. In this case, gauze act as a conductor for blood and
clot did not form on injured artery. Chitosan adhered
Fig. 8 Scanning electron microscopy of SGD and G-Ch after the successful haemostasis
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erythrocytes and platelets on gauze surface that turn to
the injury. Also chitosan can absorbed fibrin that form a
network above the injured artery. It is facilitate clot for-
mation and prevent further bleeding (Fig. 9).
Conclusion
Chitosan can bind erythrocytes in concentration-depend
manner that does not depend on its molecular weight.
In addition, chitosan-based materials affect selectively
human blood cells. Composition of chitosan with cotton
materials does not change erythrocyte shape and does
not cause agglutination. But cotton-chitosan materials
have higher adhesive properties to platelets that depend
on molecular weight and concentration of chitosan.
These materials also change platelets’ shape that prob-
able is one of the most important mechanisms of
haemostatic effect. In-vivo studies show high effective-
ness of G-Ch dressing during the trauma of large vessel
and prove blood cells changes during the chitosan-
induced haemostasis.
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